China Cord Blood Operating Expenses 2010-2022 | CORBF
China Cord Blood operating expenses from 2010 to 2022. Operating expenses can be defined as the sum of all operating expenses for the given industry.
| China Cord Blood Annual Operating Expenses (Millions of US $) |
|
|---|---|
| 2022 | $100 |
| 2021 | $94 |
| 2020 | $94 |
| 2019 | $90 |
| 2018 | $105 |
| 2017 | $72 |
| 2016 | $73 |
| 2015 | $65 |
| 2014 | $55 |
| 2013 | $51 |
| 2012 | $39 |
| 2011 | $33 |
| 2010 | $24 |
| China Cord Blood Quarterly Operating Expenses (Millions of US $) |
|
|---|---|
| 2022-03-31 | $25 |
| 2021-12-31 | $26 |
| 2021-09-30 | $24 |
| 2021-06-30 | $25 |
| 2021-03-31 | $26 |
| 2020-12-31 | $26 |
| 2020-09-30 | $22 |
| 2020-06-30 | $21 |
| 2020-03-31 | $20 |
| 2019-12-31 | $26 |
| 2019-09-30 | $24 |
| 2019-06-30 | $23 |
| 2019-03-31 | $25 |
| 2018-12-31 | $24 |
| 2018-09-30 | $21 |
| 2018-06-30 | $21 |
| 2018-03-31 | $34 |
| 2017-12-31 | $26 |
| 2017-09-30 | $24 |
| 2017-06-30 | $21 |
| 2017-03-31 | $20 |
| 2016-12-31 | $14 |
| 2016-09-30 | $19 |
| 2016-06-30 | $18 |
| 2016-03-31 | $17 |
| 2015-12-31 | $18 |
| 2015-09-30 | $19 |
| 2015-06-30 | $19 |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | $15 |
| 2014-06-30 | $15 |
| 2014-03-31 | $13 |
| 2013-12-31 | $14 |
| 2013-09-30 | $14 |
| 2013-06-30 | $13 |
| 2013-03-31 | $14 |
| 2012-12-31 | $13 |
| 2012-09-30 | $13 |
| 2012-06-30 | $11 |
| 2012-03-31 | $11 |
| 2011-12-31 | $10 |
| 2011-09-30 | $10 |
| 2011-06-30 | $9 |
| 2011-03-31 | $9 |
| 2010-12-31 | $8 |
| 2010-09-30 | $8 |
| 2010-06-30 | $7 |
| 2010-03-31 | |
| 2009-12-31 | $6 |
| 2009-09-30 | $6 |
| 2009-06-30 | |
| 2009-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $0.000B |
| Global Cord Blood Corporation operates as a life sciences company. It provides umbilical cord blood stem cells from newborn babies and offers laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company also operates as cord blood banking operator. Global Cord Blood Corporation, formerly known as China Cord Blood Corporation, is based in Hong Kong, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.405B | 26.15 |
| CVS Health (CVS) | United States | $80.076B | 9.95 |
| Elevance Health (ELV) | United States | $68.334B | 9.16 |
| Cencora (COR) | United States | $57.058B | 19.85 |
| DiDi Global (DIDIY) | China | $27.204B | 28.90 |
| Labcorp Holdings (LH) | United States | $20.694B | 16.78 |
| Natera (NTRA) | United States | $19.578B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
| CochLear (CHEOY) | Australia | $13.107B | 0.00 |
| Solventum (SOLV) | United States | $12.779B | 13.53 |
| ICON (ICLR) | Ireland | $11.862B | 11.03 |
| Revvity (RVTY) | United States | $11.266B | 19.39 |
| Viatris (VTRS) | United States | $10.880B | 3.74 |
| Medpace Holdings (MEDP) | United States | $9.173B | 24.36 |
| Avantor (AVTR) | United States | $9.056B | 13.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.822B | 0.00 |
| HealthEquity (HQY) | United States | $8.658B | 37.92 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.959B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.696B | 15.08 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.017B | 29.54 |
| BrightSpring Health Services (BTSG) | United States | $3.534B | 32.42 |
| Sotera Health (SHC) | United States | $3.188B | 18.11 |
| Surgery Partners (SGRY) | United States | $2.899B | 37.70 |
| Alignment Healthcare (ALHC) | United States | $2.602B | 0.00 |
| Concentras Parent (CON) | United States | $2.533B | 14.64 |
| Organon (OGN) | United States | $2.506B | 2.66 |
| GeneDx Holdings (WGS) | United States | $2.295B | 88.37 |
| Progyny (PGNY) | United States | $1.972B | 43.42 |
| PACS (PACS) | United States | $1.876B | 0.00 |
| Premier (PINC) | United States | $1.735B | 13.17 |
| GoodRx Holdings (GDRX) | United States | $1.689B | 33.79 |
| Ardent Health (ARDT) | United States | $1.656B | 7.06 |
| Teladoc Health (TDOC) | United States | $1.410B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.277B | 438.00 |
| Establishment Labs Holdings (ESTA) | $1.228B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.103B | 8.39 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.898B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.779B | 7.29 |
| CareDx (CDNA) | United States | $0.658B | 10.27 |
| Nutex Health (NUTX) | United States | $0.615B | 9.32 |
| Embecta (EMBC) | United States | $0.576B | 3.88 |
| InnovAge Holding (INNV) | United States | $0.571B | 0.00 |
| SBC Medicals (SBC) | United States | $0.569B | 0.00 |
| So-Young (SY) | China | $0.507B | 0.00 |
| LifeMD (LFMD) | United States | $0.504B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.476B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.474B | 10.68 |
| Omada Health (OMDA) | $0.456B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| Enhabit (EHAB) | United States | $0.337B | 27.75 |
| Oncology Institute (TOI) | United States | $0.326B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.315B | 0.00 |
| Beauty Health (SKIN) | United States | $0.209B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Pheton Holdings (PTHL) | China | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.113B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.078B | 0.00 |
| KindlyMD (NAKA) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.052B | 0.00 |
| Biodesix (BDSX) | United States | $0.046B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |